← Back to Cardlytics, Inc.
Stoqly stoqly.net Company report Β· October 27, 2026

Cardlytics, Inc.

CDLX NasdaqΒ· Services-Computer Programming, Data Processing, Etc.

Last close Β· Oct 26, 2026

$1.65

KIRA Β· Stoqly’s AI analyst, in plain words

  • Cardlytics, Inc. had $233M of revenue in fiscal 2025, down 16.2% on the year before. Over five years, revenue changed +4.5% a year on average.
  • Its operating margin was βˆ’43.6%, up 26.6Β pts: of every 100 in sales, about βˆ’44 is left after running the business.
  • Cardlytics, Inc. lost $103M in fiscal 2025.
  • Free cash flow was $8.8M in fiscal 2025, 3.8% of revenue.
  • Cardlytics, Inc. owes $160M more than it holds in cash.

Market cap

$9.5M

P/E

β€”

Revenue

$233M

Net income

βˆ’$103M

Free cash flow

$8.8M

Operating margin

βˆ’43.6%

Cardlytics, Inc. in 30 seconds Β· fiscal 2025

Weak

Are sales growing?

βˆ’16.2%

No. Sales fell 16.2% last year.

Weak

Does it make a profit?

βˆ’44.4%

No. It lost money last year.

So-so

Does profit turn into cash?

3.8%

Partly. 3.8% of sales ends up as free cash.

So-so

How healthy are the accounts?

5 / 8

Mixed. It passes 5 of 8 health tests.

For information

How is the share priced?

β€”

No P/E: it made no profit over the last four quarters.

What Cardlytics, Inc. does

No business description yet.

Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Mar 4, 2026
Legal name
Cardlytics, Inc.
CIK
0001666071
stoqly.net Β· CDLX Β· Generated October 27, 2026 Not investment advice Β· Page 1 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Cardlytics, Inc. Β· CDLX

Results and finances

The last 5 fiscal years. Amounts in USD.

Fiscal yearFY21FY22FY23FY24FY25
Sales and profit
Revenue $267M $299M $309M $278M $233M
Revenue growth 42.9% 11.8% 3.6% βˆ’10.0% βˆ’16.2%
Net interest income βˆ’$12.6M βˆ’$2.6M βˆ’$2.3M β€” β€”
Operating margin βˆ’45.9% βˆ’153.3% βˆ’43.9% βˆ’70.2% βˆ’43.6%
Net income βˆ’$129M βˆ’$465M βˆ’$135M βˆ’$189M βˆ’$103M
Net margin βˆ’48.1% βˆ’155.8% βˆ’43.6% βˆ’68.0% βˆ’44.4%
Diluted EPS βˆ’$3.99 βˆ’$13.92 βˆ’$3.69 βˆ’$3.91 βˆ’$1.95
Cash
Cash from operations βˆ’$38.5M βˆ’$53.9M βˆ’$0.2M βˆ’$8.8M $9.3M
Capital expenditure $3.1M $1.2M $0.7M $1.6M $0.5M
Free cash flow βˆ’$41.6M βˆ’$55.1M βˆ’$0.9M βˆ’$10.4M $8.8M
FCF margin βˆ’15.6% βˆ’18.4% βˆ’0.3% βˆ’3.7% 3.8%
Share buybacks $0.0M $40.0M $0.0M $0.0M β€”
Share count change 18.3% 3.8% 9.2% 32.5% 9.8%
Debt and strength
Cash and short-term investments $233M $122M $91.8M $65.6M $48.7M
Debt incl. finance leases $184M $226M $258M $259M $209M
Shareholders' equity $691M $212M $135M $70.0M βˆ’$6.5M
Current ratio 1.1x 1.0x 1.3x 1.2x 1.8x
Interest coverage βˆ’9.7x βˆ’114.4x βˆ’21.9x βˆ’22.0x β€”
Returns and quality
Return on capital βˆ’15.1% βˆ’114.5% βˆ’35.7% βˆ’58.5% βˆ’52.3%
Return on equity βˆ’30.3% βˆ’103.1% βˆ’77.8% βˆ’184.9% βˆ’326.0%
Piotroski F-score 3 2 4 2 5
Altman Z'' βˆ’0.6 βˆ’8.6 βˆ’7.0 βˆ’13.4 βˆ’17.1

Insiders bought, 12 months

$0.1M

1 insider

Insiders sold, 12 months

$0.5M

3 insiders

Of sales under plans

0%

$0.0M

How to read these numbers

Revenue:
Total sales reported in the income statement.
Operating margin:
Operating income as a share of revenue.
Net income:
Profit after all expenses, interest and tax.
Free cash flow:
Cash from operations minus capital spending.
Net debt / EBITDA:
Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Return on capital:
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
stoqly.net Β· CDLX Β· Generated October 27, 2026 Not investment advice Β· Page 2 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Cardlytics, Inc. Β· CDLX

Charts and comparison

Ten years at a glance, and how it stacks up against similar companies.

Revenue

Net income

Margins, % of revenue

Gross Operating Net

Cash vs debt (incl. leases)

Cash Debt

Free cash flow

Dividends and buybacks

Dividends Buybacks

KIRA

At $1.65 a share, the company is worth $9.5M.

Source: SEC EDGAR XBRL filings (CIK 0001666071). Data updated October 24, 2026. For information only β€” not investment advice. Check the original filings before relying on any figure.